Inventor · disambiguated record
Robert Jiang
Also filed as: JIANG ROBERT · JIANG ROBERT H
31 granted patents·9 pending applications·224 citations·filing 2001–2018
96Inventor score
Files withGILEAD SCIENCES INC16CV THERAPEUTICS INC7ABELMAN MATTHEW5CORKEY BRITTON KENNETH3ZABLOCKI JEFF3
Top patents by PatentIndex Score
40 records- 0194US9371329B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON·Filed 2014·Granted Jun 21, 2016·26 cites·2 claims
- 0294US8952034B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON·Filed 2010·Granted Feb 10, 2015·29 cites·18 claims
- 0394US8586732B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON KENNETH·Filed 2012·Granted Nov 19, 2013·29 cites·35 claims
- 0491US9676760B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2016·Granted Jun 13, 2017·7 cites·2 claims
- 0591US9598435B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2015·Granted Mar 21, 2017·9 cites·13 claims
- 0690US9193694B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2013·Granted Nov 24, 2015·11 cites·11 claims
- 0789US9458145B2Benzimidazole derivatives as bromodomain inhibitorsGILEAD SCIENCES INC·Filed 2014·Granted Oct 4, 2016·12 cites·9 claims
- 0889US8389500B2Fused heterocyclic compounds as ion channel modulatorsABELMAN MATTHEW·Filed 2009·Granted Mar 5, 2013·16 cites·24 claims
- 0985US8716319B2Substituted heterocyclic compoundsABELMAN MATTHEW·Filed 2010·Granted May 6, 2014·8 cites·4 claims
- 1085US6713650B2ABCA-1 elevating compoundsFiled 2001·Granted Mar 30, 2004·14 cites·64 claims
- 1184US9403782B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2015·Granted Aug 2, 2016·4 cites·10 claims
- 1283US9255089B2Benzimidazolone derivatives as bromodomain inhibitorsGILEAD SCIENCES INC·Filed 2014·Granted Feb 9, 2016·7 cites·19 claims
- 1383US8158810B2ALDH-2 inhibitors in the treatment of addictionZABLOCKI JEFF·Filed 2009·Granted Apr 17, 2012·7 cites·11 claims
- 1483US6900219B2ABCA-1 elevating compoundsCV THERAPEUTICS INC·Filed 2003·Granted May 31, 2005·23 cites·48 claims
- 1582US8962610B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON KENNETH·Filed 2012·Granted Feb 24, 2015·6 cites·21 claims
- 1681US9115096B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON KENNETH·Filed 2012·Granted Aug 25, 2015·5 cites·13 claims
- 1781US7423045B2ABCA1 elevating compoundsCV THERAPEUTICS INC·Filed 2006·Granted Sep 9, 2008·2 cites·20 claims
- 1876US7432276B2ABCA1 elevating compoundsCV THERAPEUTICS INC·Filed 2006·Granted Oct 7, 2008·1 cites·15 claims
- 1974US7696181B2Partial and full agonists of A1 adenosine receptorsCV THERAPEUTICS INC·Filed 2006·Granted Apr 13, 2010·1 cites·23 claims
- 2073US9108953B2Quinoline derivatives as bromodomain inhibitorsGILEAD SCIENCES INC·Filed 2014·Granted Aug 18, 2015·1 cites·18 claims
- 2173US7144871B2Partial and full agonists of A1 adenosine receptorsCV THERAPEUTICS INC·Filed 2003·Granted Dec 5, 2006·5 cites·15 claims
- 2267US2010113514A1Fused heterocyclic compounds as ion channel modulatorsGILEAD PALO ALTO INC·Filed 2009·Application pending·0 cites
- 2365US2010125091A1Substituted heterocyclic compounds as ion channel modulatorsGILEAD PALO ALTO INC·Filed 2009·Application pending·0 cites
- 2463US2009325896A1Partial and full agonists of a1 adenosine receptorsIBRAHIM PRABHA·Filed 2009·Application pending·0 cites
- 2562US8952007B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2013·Granted Feb 10, 2015·0 cites·8 claims
- 2661US8664379B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2012·Granted Mar 4, 2014·0 cites·2 claims
- 2760US2008293757A1Abca1 elevating compoundsABELMAN MATTHEW·Filed 2008·Application pending·0 cites
- 2860US2009012103A1Substituted heterocyclic compoundsABELMAN MATTHEW·Filed 2008·Application pending·0 cites
- 2959US8865739B2Substituted heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2013·Granted Oct 21, 2014·0 cites·3 claims
- 3058US9045428B2Substituted heterocyclic compoundsGILEAD SCIENCES INC·Filed 2013·Granted Jun 2, 2015·0 cites·2 claims
- 3157US8664399B2Substituted heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2012·Granted Mar 4, 2014·0 cites·2 claims
- 3255US6995285B2ABCA-1 elevating compoundsCV THERAPEUTICS INC·Filed 2002·Granted Feb 7, 2006·1 cites·7 claims
- 3355US2018282316A1Benzimidazole derivatives as bromodomain inhibitorsGILEAD SCIENCES INC·Filed 2018·Application pending·0 cites
- 3453US2009181986A1Substituted heterocyclic compoundsABELMAN MATTHEW·Filed 2009·Application pending·0 cites
- 3552US10017501B2Benzimidazole derivatives as bromodomain inhibitorsGILEAD SCIENCES INC·Filed 2016·Granted Jul 10, 2018·0 cites·15 claims
- 3651US9682998B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2016·Granted Jun 20, 2017·0 cites·12 claims
- 3746US7026321B2Substituted heterocyclic compoundsCV THERAPEUTICS INC·Filed 2004·Granted Apr 11, 2006·0 cites·33 claims
- 3846US2008207610A1Aldh-2 inhibitors in the treatment of addictionZABLOCKI JEFF·Filed 2008·Application pending·0 cites
- 3942US9695192B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2015·Granted Jul 4, 2017·0 cites·7 claims
- 4041US2008032995A1Aldh-2 inhibitors in the treatment of drug addictionZABLOCKI JEFF·Filed 2007·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →